Häckel, C G <br/><br/>
Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.  [electronic resource] 

 -  Cancer  Sep 2000 
 - 995-1003 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers, Tumor--biosynthesis<br/>Bone Neoplasms--diagnosis<br/>Cathepsin B--biosynthesis<br/>Cathepsin L<br/>Cathepsins--metabolism<br/>Chondrosarcoma--diagnosis<br/>Cohort Studies<br/>Cysteine Endopeptidases<br/>Endopeptidases<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Matrix Metalloproteinase 1--metabolism<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Recurrence<br/>Risk Factors<br/>Survival Analysis<br/>Urokinase-Type Plasminogen Activator--biosynthesis